OncoCyte Corp Valuation
| OCX Stock | USD 2.81 0.05 1.81% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. OncoCyte Corp holds a recent Real Value of $3.43 per share. The prevailing price of the company is $2.81. Our model determines the value of OncoCyte Corp from analyzing the company fundamentals such as Return On Equity of -0.76, shares owned by insiders of 12.78 %, and Current Valuation of 21.4 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting OncoCyte Corp's valuation include:
Price Book 0.5916 | Enterprise Value 21.4 M | Enterprise Value Ebitda (1.06) | Price Sales 14.8947 | Enterprise Value Revenue 7.5676 |
Undervalued
Today
Please note that OncoCyte Corp's price fluctuation is relatively risky at this time. Calculation of the real value of OncoCyte Corp is based on 3 months time horizon. Increasing OncoCyte Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for OncoCyte Corp is useful when determining the fair value of the OncoCyte stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of OncoCyte Corp. Since OncoCyte Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OncoCyte Stock. However, OncoCyte Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.81 | Real 3.43 | Target 4.19 | Hype 2.81 | Naive 3.1 |
The real value of OncoCyte Stock, also known as its intrinsic value, is the underlying worth of OncoCyte Corp Company, which is reflected in its stock price. It is based on OncoCyte Corp's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of OncoCyte Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OncoCyte Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OncoCyte Corp helps investors to forecast how OncoCyte stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OncoCyte Corp more accurately as focusing exclusively on OncoCyte Corp's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use OncoCyte Corp's intrinsic value based on its ongoing forecasts of OncoCyte Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against OncoCyte Corp's closest peers. When choosing an evaluation method for OncoCyte Corp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
OncoCyte Corp Investments |
|
OncoCyte Valuation Trend
Knowing OncoCyte Corp's actual value is paramount for traders to make sound investment determinations. OncoCyte Corp's real value is not only important for the investor to make better decisions but also for a more accurate overall view of OncoCyte Corp's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both OncoCyte Corp's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
OncoCyte Valuation Data Drivers
OncoCyte valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of OncoCyte equity instrument and the benefits of owning shares of OncoCyte Corp.
View More FundamentalsOncoCyte Market Cap
OncoCyte Corp is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 90.37 Billion. OncoCyte Corp adds roughly 36.89 Million in market capitalization claiming only tiny portion of equities under Health Care industry.OncoCyte Corp Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining OncoCyte Corp's current stock value. Our valuation model uses many indicators to compare OncoCyte Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OncoCyte Corp competition to find correlations between indicators driving OncoCyte Corp's intrinsic value. More Info.OncoCyte Corp is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Price To Book Ratio is likely to drop to 0.94 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value OncoCyte Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OncoCyte Corp's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OncoCyte Corp's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates OncoCyte Corp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in OncoCyte Corp and how it compares across the competition.
About OncoCyte Corp Valuation
The stock valuation mechanism determines the current worth of OncoCyte Corp on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of OncoCyte Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OncoCyte Corp based exclusively on its fundamental and basic technical indicators. By analyzing OncoCyte Corp's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of OncoCyte Corp's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of OncoCyte Corp. We calculate exposure to OncoCyte Corp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to OncoCyte Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 501 K | 526 K | |
| Pretax Profit Margin | (16.54) | (17.36) | |
| Operating Profit Margin | (15.21) | (15.97) | |
| Net Loss | (18.48) | (19.41) | |
| Gross Profit Margin | 0.33 | 0.35 |
8 Steps to conduct OncoCyte Corp's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OncoCyte Corp's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OncoCyte Corp's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OncoCyte Corp's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OncoCyte Corp's revenue streams: Identify OncoCyte Corp's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OncoCyte Corp's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OncoCyte Corp's growth potential: Evaluate OncoCyte Corp's management, business model, and growth potential.
- Determine OncoCyte Corp's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OncoCyte Corp's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
OncoCyte Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as OncoCyte Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 7.7 M |
OncoCyte Corp Current Valuation Indicators
Valuation refers to the process of determining the present value of OncoCyte Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value OncoCyte we look at many different elements of the entity such as OncoCyte's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. OncoCyte Corp's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final OncoCyte Corp's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as OncoCyte Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use OncoCyte Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes OncoCyte Corp's worth.When determining whether OncoCyte Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OncoCyte Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncocyte Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncocyte Corp Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.Note that the OncoCyte Corp information on this page should be used as a complementary analysis to other OncoCyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for OncoCyte Stock analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is OncoCyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OncoCyte Corp. If investors know OncoCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OncoCyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.37) | Revenue Per Share 0.196 | Quarterly Revenue Growth 0.146 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of OncoCyte Corp is measured differently than its book value, which is the value of OncoCyte that is recorded on the company's balance sheet. Investors also form their own opinion of OncoCyte Corp's value that differs from its market value or its book value, called intrinsic value, which is OncoCyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OncoCyte Corp's market value can be influenced by many factors that don't directly affect OncoCyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OncoCyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if OncoCyte Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OncoCyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.